Outstanding Potential15 May 2020 11:05
Absolutely blown away by Sir Al. We're now on the cusp of revolutionising:
Testing capability: 'the development of a COVID-19 antigen rapid saliva test with Cytiva which continues apace'
Treatment: 'patients already infected by the virus, to help treat and prevent disease progression'
and just when you think it can't get better...
Cure: 'therapy that could help prevent infection and limit the progression of the disease'
Looks like we've got all bases covered and all can be developed apace, certainly it appears faster than traditional approaches so we could end up being the preferred option for all three.
Oh, plus curing cancer. Mustn't forget that. Well done to all at Avacta and good luck with your continued efforts that will save the world (and my bank balance - naturally)